OBIO
NASDAQ
$3.71
Orchestra BioMed Holdings Inc (OBIO)
Orchestra BioMed Holdings, Inc. is a therapeutic device company that develops therapeutic treatments and products for cardiovascular diseases. The company is headquartered in New Hope, Pennsylvania.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $12.17 (+228.03%)
Market Cap
$214M
Free Cash Flow Yield
-25.74%
Beta (5Y)
1.65
Price Chart
Valuation
Market Cap$214M
P/S6.68
P/B5.37
Profitability
Total Revenue (TTM)$33M
Gross Profit (TTM)$33M
EBITDA-$55M
Profit Margin-167%
Operating Margin-20069%
EPS-$1.11
Financial Health
Debt-to-Equity36.4%
Free Cash Flow Yield-25.74%
Growth & Risk
Beta (5Y)1.65
Sharpe Ratio0.52